Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pedrazzoli

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Journal of the National Cancer Institute|January 1, 2009
Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'Marco Bregni, Paolo Pedrazzoli
Future Oncology (London, England)|August 25, 2021
G-CSF and G-CSF-related vasculitis: a systematic review of the literature and intriguing future research perspectivesMarta Muzzana, Paolo Pedrazzoli, Angioletta Lasagna
Nutrition (Burbank, Los Angeles County, Calif.)|March 21, 2017
Author response to commentary re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey"Riccardo Caccialanza, Emanuele Cereda, Paolo Pedrazzoli
Drugs in Context|July 11, 2024
What are we doing concretely for the food prevention of cancer? Nutrition between scientific evidence and myopic policiesFrancesco Serra, Riccardo Caccialanza, Paolo Pedrazzoli
Immunotherapy|September 29, 2021
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of researchAngioletta Lasagna, Marta Muzzana, Paolo Pedrazzoli
Immunotherapy|April 6, 2011
Is immunotherapy re-entering the kidney cancer arena from the back door? Considerations from the Phase I/II study of siltuximabCamillo Porta, Paolo Pedrazzoli, Chiara Paglino
Nature Clinical Practice. Oncology|November 29, 2007
Are metastatic testicular tumors curable with high-dose chemotherapy and stem-cell rescue?Giovanni Rosti, Ugo De Giorgi, Paolo Pedrazzoli
Frontiers in Nutrition|May 9, 2024
Nutritional care for cancer patients: are we doing enough?Valentina Da Prat, Paolo Pedrazzoli, Riccardo Caccialanza
ESMO Open|December 7, 2017
The integrating nutritional therapy in oncology (INTO) project: rationale, structure and preliminary resultsRiccardo Caccialanza, Francesco De Lorenzo, Paolo Pedrazzoli
The New England Journal of Medicine|October 31, 2007
Germ-cell tumorsUgo De Giorgi, Paolo Pedrazzoli, Giovanni Rosti, et al.
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Journal of the National Cancer Institute|January 1, 2009
Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'Marco Bregni, Paolo Pedrazzoli
Future Oncology (London, England)|August 25, 2021
G-CSF and G-CSF-related vasculitis: a systematic review of the literature and intriguing future research perspectivesMarta Muzzana, Paolo Pedrazzoli, Angioletta Lasagna
Nutrition (Burbank, Los Angeles County, Calif.)|March 21, 2017
Author response to commentary re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey"Riccardo Caccialanza, Emanuele Cereda, Paolo Pedrazzoli
Drugs in Context|July 11, 2024
What are we doing concretely for the food prevention of cancer? Nutrition between scientific evidence and myopic policiesFrancesco Serra, Riccardo Caccialanza, Paolo Pedrazzoli
Immunotherapy|September 29, 2021
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of researchAngioletta Lasagna, Marta Muzzana, Paolo Pedrazzoli
Immunotherapy|April 6, 2011
Is immunotherapy re-entering the kidney cancer arena from the back door? Considerations from the Phase I/II study of siltuximabCamillo Porta, Paolo Pedrazzoli, Chiara Paglino
Nature Clinical Practice. Oncology|November 29, 2007
Are metastatic testicular tumors curable with high-dose chemotherapy and stem-cell rescue?Giovanni Rosti, Ugo De Giorgi, Paolo Pedrazzoli
Frontiers in Nutrition|May 9, 2024
Nutritional care for cancer patients: are we doing enough?Valentina Da Prat, Paolo Pedrazzoli, Riccardo Caccialanza
ESMO Open|December 7, 2017
The integrating nutritional therapy in oncology (INTO) project: rationale, structure and preliminary resultsRiccardo Caccialanza, Francesco De Lorenzo, Paolo Pedrazzoli
The New England Journal of Medicine|October 31, 2007
Germ-cell tumorsUgo De Giorgi, Paolo Pedrazzoli, Giovanni Rosti, et al.
Pageof 25